This study is testing whether adding a drug called ribociclib to standard hormone therapy (letrozole) helps shrink breast tumors more effectively before surgery. The goal is to help more women achieve excellent outcomes without needing chemotherapy. Researchers are comparing the …
Phase: PHASE2 • Sponsor: Qamar Khan • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC